More from Stocks
Rather than get burned by issues with suddenly inflated prices that eventually could crash back to earth, go with tried-and true-names in technology development.
The pharmaceutical giant gained an analyst's buy recommendation but its technical signals are lackluster at best.
The charts indicate that the shares of the semiconductor maker are likely to trade sideways for a while even as it gains an analyst's buy recommendation.
Macerich is a blast from the past that still looks good today.